Table of Contents Author Guidelines Submit a Manuscript
PPAR Research
Volume 2008, Article ID 176275, 9 pages
http://dx.doi.org/10.1155/2008/176275
Review Article

Role of the Peroxisome Proliferator-Activated Receptors, Adenosine Monophosphate-Activated Kinase, and Adiponectin in the Ovary

Unité de Physiologie de la Reproduction et des Comportements, Institut National de la Recherche Agronomique, Nouzilly 37380, France

Received 1 June 2007; Accepted 19 July 2007

Academic Editor: Pascal Froment

Copyright © 2008 Joëlle Dupont et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. R. Butler, “Nutritional interactions with reproductive performance in dairy cattle,” Animal Reproduction Science, vol. 60-61, pp. 449–457, 2000. View at Publisher · View at Google Scholar
  2. R. Fernandez-Fernandez, A. C. Martini, V. M. Navarro et al., “Novel signals for the integration of energy balance and reproduction,” Molecular and Cellular Endocrinology, vol. 254-255, pp. 127–132, 2006. View at Publisher · View at Google Scholar
  3. D. J. Burks, J. F. de Mora, M. Schubert et al., “IRS-2 pathways integrate female reproduction and energy homeostasis,” Nature, vol. 407, no. 6802, pp. 377–382, 2000. View at Publisher · View at Google Scholar
  4. J. C. Bruning, D. Gautam, D. J. Burks et al., “Role of brain insulin receptor in control of body weight and reproduction,” Science, vol. 289, no. 5487, pp. 2122–2125, 2000. View at Publisher · View at Google Scholar
  5. A. Dunaif, “Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis,” Endocrine Reviews, vol. 18, no. 6, pp. 774–800, 1997. View at Publisher · View at Google Scholar
  6. M. J. Iuorno and J. E. Nestler, “Insulin-lowering drugs in polycystic ovary syndrome,” Obstetrics and Gynecology Clinics of North America, vol. 28, no. 1, pp. 153–164, 2001. View at Publisher · View at Google Scholar
  7. E. Seli and A. J. Duleba, “Treatment of PCOS with metformin and other insulin-sensitizing agents,” Current Diabetes Reports, vol. 4, no. 1, pp. 69–75, 2004. View at Publisher · View at Google Scholar
  8. J. M. Lehmann, L. B. Moore, T. A. Smith-Oliver, W. O. Wilkison, T. M. Willson, and S. A. Kliewer, “An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ),” Journal of Biological Chemistry, vol. 270, no. 22, pp. 12953–12956, 1995. View at Publisher · View at Google Scholar
  9. N. Musi, M. F. Hirshman, J. Nygren et al., “Metformin increases AMP-activated protein-kinase activity in skeletal muscle of subjects with type 2 diabetes,” Diabetes, vol. 51, no. 7, pp. 2074–2081, 2002. View at Publisher · View at Google Scholar
  10. M. S. Ardawi and A. A. Rouzi, “Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome,” Fertility and Sterility, vol. 83, no. 6, pp. 1708–1716, 2005. View at Publisher · View at Google Scholar
  11. T. Kadowaki and T. Yamauchi, “Adiponectin and adiponectin receptors,” Endocrine Reviews, vol. 26, no. 3, pp. 439–451, 2005. View at Publisher · View at Google Scholar
  12. C. Chabrolle, L. Tosca, and J. Dupont, “Regulation of adiponectin and its receptors in rat ovary by human chorionic gonadotrophin treatment and potential involvement of adiponectin in granulosa cell steroidogenesis,” Reproduction, vol. 133, no. 4, pp. 719–731, 2007. View at Publisher · View at Google Scholar
  13. C. Chabrolle, L. Tosca, S. Crochet, S. Tesseraud, and J. Dupont, “Expression of adiponectin and its receptors (AdipoR1 and AdipoR2) in chicken ovary: potential role in ovarian steroidogenesis,” to appear in Domestic Animal Endocrinology. View at Publisher · View at Google Scholar
  14. R. Mattos, C. R. Staples, and W. W. Thatcher, “Effects of dietary fatty acids on reproduction in ruminants,” Reviews of Reproduction, vol. 5, no. 1, pp. 38–45, 2000. View at Publisher · View at Google Scholar
  15. C. M. Garcia-Bojalil, C. R. Staples, C. A. Risco, J. D. Savio, and W. W. Thatcher, “Protein degradability and calcium salts of long-chain fatty acids in the diets of lactating dairy cows: reproductive responses,” Journal of Dairy Science, vol. 81, no. 5, pp. 1385–1395, 1998. View at Google Scholar
  16. B. P. Kota, T. H.-W. Huang, and B. D. Roufogalis, “An overview on biological mechanisms of PPARs,” Pharmacological Research, vol. 51, no. 2, pp. 85–94, 2005. View at Publisher · View at Google Scholar
  17. D. G. Hardie and D. Carling, “The AMP-activated protein kinase—fuel gauge of the mammalian cell?” European Journal of Biochemistry, vol. 246, no. 2, pp. 259–273, 1997. View at Publisher · View at Google Scholar
  18. S. Han and J. Roman, “Rosiglitazone suppresses human lung carcinoma cell growth through PPARγ-dependent and PPARγ-independent signal pathways,” Molecular Cancer Therapeutics, vol. 5, no. 2, pp. 430–437, 2006. View at Publisher · View at Google Scholar
  19. N. K. LeBrasseur, M. Kelly, T.-S. Tsao et al., “Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues,” American Journal of Physiology, vol. 291, no. 1, pp. E175–E181, 2006. View at Publisher · View at Google Scholar
  20. L. G. Fryer, A. Parbu-Patel, and D. Carling, “The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways,” Journal of Biological Chemistry, vol. 277, no. 28, pp. 25226–25232, 2002. View at Publisher · View at Google Scholar
  21. G. Pilon, P. Dallaire, and A. Marette, “Inhibition of inducible nitric-oxide synthase by activators of AMP-activated protein kinase: a new mechanism of action of insulin-sensitizing drugs,” Journal of Biological Chemistry, vol. 279, no. 20, pp. 20767–20774, 2004. View at Publisher · View at Google Scholar
  22. M. R. Owen, E. Doran, and A. P. Halestrap, “Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain,” Biochemical Journal, vol. 348, no. 3, pp. 607–614, 2000. View at Publisher · View at Google Scholar
  23. C. M. Komar, “Peroxisome proliferator-activated receptors (PPARs) and ovarian function—implications for regulating steroidogenesis, differentiation, and tissue remodeling,” Reproductive Biology and Endocrinology, vol. 3, p. 31, 2005. View at Publisher · View at Google Scholar
  24. K. S. Miyata, S. E. McCaw, S. L. Marcus, R. A. Rachubinski, and J. P. Capone, “The peroxisome proliferator-activated receptor interacts with the retinoid X receptor in vivo,” Gene, vol. 148, no. 2, pp. 327–330, 1994. View at Publisher · View at Google Scholar
  25. B. Desvergne and W. Wahli, “Peroxisome proliferator-activated receptors: nuclear control of metabolism,” Endocrine Reviews, vol. 20, no. 5, pp. 649–688, 1999. View at Publisher · View at Google Scholar
  26. F. Picard and J. Auwerx, “PPARγ and glucose homeostasis,” Annual Review of Nutrition, vol. 22, pp. 167–197, 2002. View at Publisher · View at Google Scholar
  27. Y. Kobayashi, S. Ueki, G. Mahemuti et al., “Physiological levels of 15-deoxy-?12,14-prostaglandin J2 prime eotaxin-induced chemotaxis on human eosinophils through peroxisome proliferator-activated receptor-? ligation,” Journal of Immunology, vol. 175, no. 9, pp. 5744–5750, 2005. View at Google Scholar
  28. T. Leff, “AMP-activated protein kinase regulates gene expression by direct phosphorylation of nuclear proteins,” Biochemical Society Transactions, vol. 31, part 1, pp. 224–227, 2003. View at Google Scholar
  29. O. Braissant, F. Foufelle, C. Scotto, M. Dauça, and W. Wahli, “Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-α, -β, and -γ in the adult rat,” Endocrinology, vol. 137, no. 1, pp. 354–366, 1996. View at Publisher · View at Google Scholar
  30. G. Krey, O. Braissant, F. L'Horset et al., “Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay,” Molecular Endocrinology, vol. 11, no. 6, pp. 779–791, 1997. View at Publisher · View at Google Scholar
  31. K. Schoonjans, B. Staels, and J. Auwerx, “Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression,” Journal of Lipid Research, vol. 37, no. 5, pp. 907–925, 1996. View at Google Scholar
  32. Y.-C. Zhou and D. J. Waxman, “Activation of peroxisome proliferator-activated receptors by chlorinated hydrocarbons and endogenous steroids,” Environmental Health Perspectives, vol. 106, 4, pp. 983–988, 1998. View at Publisher · View at Google Scholar
  33. A. Shalev, C. A. Siegrist-Kaiser, P. M. Yen et al., “The peroxisome proliferator-activated receptor a is a phosphoprotein: regulation by insulin,” Endocrinology, vol. 137, no. 10, pp. 4499–4502, 1996. View at Publisher · View at Google Scholar
  34. C. Fiévet, J.-C. Fruchart, and B. Staels, “PPARα and PPARγ dual agonists for the treatment of type 2 diabetes and the metabolic syndrome,” Current Opinion in Pharmacology, vol. 6, no. 6, pp. 606–614, 2006. View at Publisher · View at Google Scholar
  35. D. G. Hardie, “The AMP-activated protein kinase pathway—new players upstream and downstream,” Journal of Cell Science, vol. 117, no. 23, pp. 5479–5487, 2004. View at Publisher · View at Google Scholar
  36. T. Hayashi, M. F. Hirshman, E. J. Kurth, W. W. Winder, and L. J. Goodyear, “Evidence for 5' AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport,” Diabetes, vol. 47, no. 8, pp. 1369–1373, 1998. View at Publisher · View at Google Scholar
  37. J. Mu, J. T. Brozinick Jr., O. Valladares, M. Bucan, and M. J. Birnbaum, “A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle,” Molecular Cell, vol. 7, no. 5, pp. 1085–1094, 2001. View at Publisher · View at Google Scholar
  38. T. Yamauchi, J. Kamon, Y. Minokoshi et al., “Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase,” Nature Medicine, vol. 8, no. 11, pp. 1288–1295, 2002. View at Publisher · View at Google Scholar
  39. Y. Minokoshi, Y.-B. Kim, O. D. Peroni et al., “Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase,” Nature, vol. 415, no. 6869, pp. 339–343, 2002. View at Publisher · View at Google Scholar
  40. J. M. Corton, J. G. Gillespie, S. A. Hawley, and D. G. Hardie, “5-aminoimidazole-4-carboxamide ribonucleoside—a specific method for activating AMP-activated protein kinase in intact cells?” European Journal of Biochemistry, vol. 229, no. 2, pp. 558–565, 1995. View at Publisher · View at Google Scholar
  41. B. B. Kahn, T. Alquier, D. Carling, and D. G. Hardie, “AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism,” Cell Metabolism, vol. 1, no. 1, pp. 15–25, 2005. View at Publisher · View at Google Scholar
  42. D. G. Hardie, “New roles for the LKB1AMPK pathway,” Current Opinion in Cell Biology, vol. 17, no. 2, pp. 167–173, 2005. View at Publisher · View at Google Scholar
  43. T. Yamauchi, Y. Nio, T. Maki et al., “Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions,” Nature Medicine, vol. 13, no. 3, pp. 332–339, 2007. View at Publisher · View at Google Scholar
  44. P. E. Scherer, S. Williams, M. Fogliano, G. Baldini, and H. F. Lodish, “A novel serum protein similar to C1q, produced exclusively in adipocytes,” Journal of Biological Chemistry, vol. 270, no. 45, pp. 26746–26749, 1995. View at Publisher · View at Google Scholar
  45. K. Maeda, K. Okubo, I. Shimomura, T. Funahashi, Y. Matsuzawa, and K. Matsubara, “cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1,” Biochemical and Biophysical Research Communications, vol. 221, no. 2, pp. 286–289, 1996. View at Publisher · View at Google Scholar
  46. U. B. Pajvani and P. E. Scherer, “Adiponectin: systemic contributor to insulin sensitivity,” Current Diabetes Reports, vol. 3, no. 3, pp. 207–213, 2003. View at Publisher · View at Google Scholar
  47. T. Yamauchi, J. Kamon, Y. Minokoshi et al., “Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase,” Nature Medicine, vol. 8, no. 11, pp. 1288–1295, 2002. View at Publisher · View at Google Scholar
  48. M. Iwaki, M. Matsuda, N. Maeda et al., “Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors,” Diabetes, vol. 52, no. 7, pp. 1655–1663, 2003. View at Publisher · View at Google Scholar
  49. N. Maeda, M. Takahashi, T. Funahashi et al., “PPAR? ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein,” Diabetes, vol. 50, no. 9, pp. 2094–2099, 2001. View at Publisher · View at Google Scholar
  50. A. R. Nawrocki, M. W. Rajala, E. Tomas et al., “Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor ? agonists,” Journal of Biological Chemistry, vol. 281, no. 5, pp. 2654–2660, 2006. View at Publisher · View at Google Scholar
  51. S. Ledoux, D. B. Campos, F. L. Lopes, M. Dobias-Goff, M.-F. Palin, and B. D. Murphy, “Adiponectin induces periovulatory changes in ovarian follicular cells,” Endocrinology, vol. 147, no. 11, pp. 5178–5186, 2006. View at Publisher · View at Google Scholar
  52. C. M. Komar, O. Braissant, W. Wahli, and T. E. Curry Jr., “Expression and localization of PPARs in the rat ovary during follicular development and the periovulatory period,” Endocrinology, vol. 142, no. 11, pp. 4831–4838, 2001. View at Publisher · View at Google Scholar
  53. S. S. Lee, T. Pineau, J. Drago et al., “Targeted disruption of the a isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators,” Molecular and Cellular Biology, vol. 15, no. 6, pp. 3012–3022, 1995. View at Google Scholar
  54. Y. Barak, D. Liao, W. He et al., “Effects of peroxisome proliferator-activated receptor d on placentation, adiposity, and colorectal cancer,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 1, pp. 303–308, 2002. View at Publisher · View at Google Scholar
  55. J. M. Peters, S. S. Lee, W. Li et al., “Growths, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor ß(d),” Molecular and Cellular Biology, vol. 20, no. 14, pp. 5119–5128, 2000. View at Publisher · View at Google Scholar
  56. S. Gasic, Y. Bodenburg, M. Nagamani, A. Green, and R. J. Urban, “Troglitazone inhibits progesterone production in porcine granulosa cells,” Endocrinology, vol. 139, no. 12, pp. 4962–4966, 1998. View at Publisher · View at Google Scholar
  57. P. Froment, S. Fabre, J. Dupont et al., “Expression and functional role of peroxisome proliferator-activated receptor-? in ovarian folliculogenesis in the sheep,” Biology of Reproduction, vol. 69, no. 5, pp. 1665–1674, 2003. View at Publisher · View at Google Scholar
  58. C. Komar, “Initiation of peroxysome proliferator-activated receptor gamma (PPARg) expression in the neonatal rat ovary,” in Proceedings of the 38th Annual Meeting of the Society for the Study of Reproduction, Quebec City, Quebec, Canada, July 2005.
  59. Y. Cui, K. Miyoshi, E. Claudio et al., “Loss of the peroxisome proliferation-activated receptor gamma (PPAR?) does not affect mammary development and propensity for tumor formation but leads to reduced fertility,” Journal of Biological Chemistry, vol. 277, no. 20, pp. 17830–17835, 2002. View at Publisher · View at Google Scholar
  60. L. Tosca, P. Froment, P. Solnais, P. Ferré, F. Foufelle, and J. Dupont, “Adenosine 5-monophosphate-activated protein kinase regulates progesterone secretion in rat granulosa cells,” Endocrinology, vol. 146, no. 10, pp. 4500–4513, 2005. View at Publisher · View at Google Scholar
  61. L. Tosca, P. Solnais, P. Ferré, F. Foufelle, and J. Dupont, “Metformin-induced stimulation of adenosine 5monophosphate-activated protein kinase (PRKA) impairs progesterone secretion in rat granulosa cells,” Biology of Reproduction, vol. 75, no. 3, pp. 342–351, 2006. View at Publisher · View at Google Scholar
  62. S. M. Downs, E. R. Hudson, and D. G. Hardie, “A potential role for AMP-activated protein kinase in meiotic induction in mouse oocytes,” Developmental Biology, vol. 245, no. 1, pp. 200–212, 2002. View at Publisher · View at Google Scholar
  63. L. Tosca, C. Chabrolle, S. Uzbekova, and J. Dupont, “Effects of metformin on bovine granulosa cells steroidogenesis: possible involvement of adenosine 5monophosphate-activated protein kinase (AMPK),” Biology of Reproduction, vol. 76, no. 3, pp. 368–378, 2007. View at Publisher · View at Google Scholar
  64. M. A. Mayes, M. F. Laforest, C. Guillemette, R. B. Gilchrist, and F. J. Richard, “Adenosine 5-monophosphate kinase-activated protein kinase (PRKA) activators delay meiotic resumption in porcine oocytes,” Biology of Reproduction, vol. 76, no. 4, pp. 589–597, 2007. View at Publisher · View at Google Scholar
  65. L. Tosca, S. Crochet, P. Ferré, F. Foufelle, S. Tesseraud, and J. Dupont, “AMP-activated protein kinase activation modulates progesterone secretion in granulosa cells from hen preovulatory follicles,” Journal of Endocrinology, vol. 190, no. 1, pp. 85–97, 2006. View at Publisher · View at Google Scholar
  66. B. Viollet, F. Andreelli, S. B. Jørgensen et al., “The AMP-activated protein kinase a2 catalytic subunit controls whole-body insulin sensitivity,” Journal of Clinical Investigation, vol. 111, no. 1, pp. 91–98, 2003. View at Publisher · View at Google Scholar
  67. K. Ma, A. Cabrero, P. K. Saha et al., “Increased ß-oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin,” Journal of Biological Chemistry, vol. 277, no. 38, pp. 34658–34661, 2002. View at Publisher · View at Google Scholar
  68. P. Froment, F. Gizard, D. Defever, B. Staels, J. Dupont, and P. Monget, “Peroxisome proliferator-activated receptors in reproductive tissues: from gametogenesis to parturition,” Journal of Endocrinology, vol. 189, no. 2, pp. 199–209, 2006. View at Publisher · View at Google Scholar
  69. Y.-M. Mu, T. Yanase, Y. Nishi et al., “Insulin sensitizer, troglitazone, directly inhibits aromatase activity in human ovarian granulosa cells,” Biochemical and Biophysical Research Communications, vol. 271, no. 3, pp. 710–713, 2000. View at Publisher · View at Google Scholar
  70. K. Toda, T. Okada, C. Miyaura, and T. Saibara, “Fenofibrate, a ligand for PPARα, inhibits aromatase cytochrome P450 expression in the ovary of mouse,” Journal of Lipid Research, vol. 44, no. 2, pp. 265–270, 2003. View at Publisher · View at Google Scholar
  71. T. N. Lovekamp and B. J. Davis, “Mono-(2-ethylhexyl) phthalate suppresses aromatase transcript levels and estradiol production in cultured rat granulosa cells,” Toxicology and Applied Pharmacology, vol. 172, no. 3, pp. 217–224, 2001. View at Publisher · View at Google Scholar
  72. R. Mansfield, R. Galea, M. Brincat, D. Hole, and H. Mason, “Metformin has direct effects on human ovarian steroidogenesis,” Fertility and Sterility, vol. 79, no. 4, pp. 956–962, 2003. View at Publisher · View at Google Scholar
  73. A. La Marca, T. O. Egbe, G. Morgante, T. Paglia, A. Ciani, and V. De Leo, “Metformin treatment reduces ovarian cytochrome P-450c17α response to human chorionic gonadotrophin in women with insulin resistance-related polycystic ovary syndrome,” Human Reproduction, vol. 15, no. 1, pp. 21–23, 2000. View at Publisher · View at Google Scholar
  74. Y.-H. Liu, E.-M. Tsai, Y.-L. Chen et al., “Serum adiponectin levels increase after human chorionic gonadotropin treatment during in vitro fertilization,” Gynecologic and Obstetric Investigation, vol. 62, no. 2, pp. 61–65, 2006. View at Publisher · View at Google Scholar
  75. B. Löhrke, T. Viergutz, S. K. Shahi et al., “Detection and functional characterisation of the transcription factor peroxisome proliferator-activated receptor ? in lutein cells,” Journal of Endocrinology, vol. 159, no. 3, pp. 429–439, 1998. View at Publisher · View at Google Scholar
  76. M. Mohan, S. Ryder, P. L. Claypool, R. D. Geisert, and J. R. Malayer, “Analysis of gene expression in the bovine blastocyst produced in vitro using suppression-subtractive hybridization,” Biology of Reproduction, vol. 67, no. 2, pp. 447–453, 2002. View at Publisher · View at Google Scholar
  77. J. R. Wood, D. A. Dumesic, D. H. Abbott, and J. F. Strauss III, “Molecular abnormalities in oocytes from women with polycystic ovary syndrome revealed by microarray analysis,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 2, pp. 705–713, 2007. View at Publisher · View at Google Scholar
  78. M. Mitchell, D. T. Armstrong, R. L. Robker, and R. J. Norman, “Adipokines: implications for female fertility and obesity,” Reproduction, vol. 130, no. 5, pp. 583–597, 2005. View at Publisher · View at Google Scholar
  79. T. Sir-Petermann, B. Echiburú, M. M. Maliqueo et al., “Serum adiponectin and lipid concentrations in pregnant women with polycystic ovary syndrome,” Human Reproduction, vol. 22, no. 7, pp. 1830–1836, 2007. View at Publisher · View at Google Scholar
  80. G. Pincus and E. V. Enzmann, “The comparative behavior of mammalian eggs in vivo and in vitro,” The Journal of Experimental Medicine, vol. 62, pp. 665–675, 1935. View at Publisher · View at Google Scholar
  81. R. G. Edwards, “Maturation in vitro of mouse, sheep, cow, pig, rhesus monkey and human ovarian oocytes,” Nature, vol. 208, no. 8, pp. 349–351, 1965. View at Publisher · View at Google Scholar
  82. J. Chen, E. Hudson, M. M. Chi et al., “AMPK regulation of mouse oocyte meiotic resumption in vitro,” Developmental Biology, vol. 291, no. 2, pp. 227–238, 2006. View at Publisher · View at Google Scholar
  83. C. LaRosa and S. M. Downs, “Stress stimulates AMP-activated protein kinase and meiotic resumption in mouse oocytes,” Biology of Reproduction, vol. 74, no. 3, pp. 585–592, 2006. View at Publisher · View at Google Scholar
  84. S. Bilodeau-Goeseels, M. Sasseville, C. Guillemette, and F. J. Richard, “Effects of adenosine monophosphate-activated kinase activators on bovine oocyte nuclear maturation in vitro,” Molecular Reproduction and Development, vol. 74, no. 8, pp. 1021–1034, 2007. View at Publisher · View at Google Scholar
  85. L. Tosca, S. Uzbekova, C. Chabrolle, and J. Dupont, “Possible role of AMPK in the metformin-mediated arrest of bovine oocytes at the GV stage during in vitro maturation,” to appear in Biology of Reproduction.
  86. L. A. Stadtmauer, S. K. Toma, R. M. Riehl, and L. M. Talbert, “Impact of metformin therapy on ovarian stimulation and outcome in ‘coasted’ patients with polycystic ovary syndrome undergoing in-vitro fertilization,” Reproductive Biomedicine Online, vol. 5, no. 2, pp. 112–116, 2002. View at Google Scholar
  87. R. S. Legro, H. X. Barnhart, W. D. Schlaff et al., “Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome,” New England Journal of Medicine, vol. 356, no. 6, pp. 551–566, 2007. View at Publisher · View at Google Scholar